Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7VFA

the complex of SARS-CoV2 3CL and NB1A2

Summary for 7VFA
Entry DOI10.2210/pdb7vfa/pdb
DescriptorNB1A2, 3C-like proteinase, SULFATE ION, ... (4 entities in total)
Functional Keywordssars-cov2, 3cl, nanobody, viral protein, viral protein-immune system complex, viral protein/immune system
Biological sourceCamelus bactrianus
More
Total number of polymer chains2
Total formula weight50227.00
Authors
Sun, Z.C.,Wang, L.,Geng, Y. (deposition date: 2021-09-11, release date: 2022-03-30, Last modification date: 2024-10-30)
Primary citationSun, Z.,Wang, L.,Li, X.,Fan, C.,Xu, J.,Shi, Z.,Qiao, H.,Lan, Z.,Zhang, X.,Li, L.,Zhou, X.,Geng, Y.
An extended conformation of SARS-CoV-2 main protease reveals allosteric targets.
Proc.Natl.Acad.Sci.USA, 119:-, 2022
Cited by
PubMed Abstract: SignificanceThe coronavirus main protease (M) is required for viral replication. Here, we obtained the extended conformation of the native monomer of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) M by trapping it with nanobodies and found that the catalytic domain and the helix domain dissociate, revealing allosteric targets. Another monomeric state is termed compact conformation and is similar to one protomer of the dimeric form. We designed a Nanoluc Binary Techonology (NanoBiT)-based high-throughput allosteric inhibitor assay based on structural conformational change. Our results provide insight into the maturation, dimerization, and catalysis of the coronavirus M and pave a way to develop an anticoronaviral drug through targeting the maturation process to inhibit the autocleavage of M.
PubMed: 35324337
DOI: 10.1073/pnas.2120913119
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.75 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon